NCT04053439View on ClinicalTrials.gov

Clonal Hematopoiesis is a Risk Factor for Chemotherapy-Related Complications

RecruitingOBSERVATIONAL
Enrollment

188

Participants

Timeline

Start Date

August 8, 2019

Primary Completion Date

January 31, 2026

Study Completion Date

September 30, 2026

Conditions
LymphomaChemotherapeutic Toxicity
Interventions
OTHER

Blood test for determination of CHIP

Patients will have one additional blood draw to be sent for DNA extraction and sequencing for CHIP.

Trial Locations (1)

M4N 3M5

RECRUITING

Sunnybrook Health Sciences Centre, Toronto

All Listed Sponsors
collaborator

The Leukemia and Lymphoma Society

OTHER

collaborator

Queen's University

OTHER

lead

Sunnybrook Health Sciences Centre

OTHER